by | Nov 18, 2021 | News
Since COVID-19 reared its ugly head more than 18 months ago, public health experts have longed to bolster their pandemic toolbox with a pill that could easily treat coronavirus. They may finally have one. Fluvoxamine, an off-patent, widely available antidepressant,... by | Nov 17, 2021 | News
As the US prepares to enter into its third winter season dealing with COVID-19, an unanswered question—first asked back in the earliest days of the pandemic—remains: When will it be over? Unfortunately, the answer may be “never”—many experts no longer... by | Nov 16, 2021 | News
To try to gauge where things stand, the reporter asked a number of infectious diseases experts — public health experts, epidemiologists, immunologists, and virologists — about the risks they are willing to take now, figuring that their answers might give... by | Nov 16, 2021 | News
Combining electroencephalogram (EEG) data with clinical observations can help doctors to better determine whether generalized epilepsy patients will respond to treatment, according to a study led by Rutgers researchers. The study, which was published this week... 
by | Nov 15, 2021 | News
As you read this, a worker in a tropical rainforest is clearing brush in preparation for a commercial agricultural operation. He’s far from the markets of home, and so he takes his food as he finds it, likely killing a bird or small mammal—a monkey, say, or a bat—to...